Cytotoxic hypothemycin analogues from Hypomyces subiculosus

Area of Science:

• Natural Product Chemistry
• Medicinal Chemistry
• Mycology

Background:

• Hypothemycins are a class of fungal metabolites with potential biological activities.
• The fungal strains Hypomyces subiculosus DSM 11931 and DSM 11932 were previously uninvestigated for novel compound production.

Purpose of the Study:

• To isolate and characterize new analogues of hypothemycin from Hypomyces subiculosus.
• To evaluate the cytotoxic activity of the isolated compounds, particularly against cancer cell lines harboring specific genetic mutations.

Main Methods:

• Isolation of compounds using chromatographic techniques.
• Structure elucidation employing spectroscopic methods (NMR, MS) and X-ray crystallography.
• Cytotoxicity assays on various cancer cell lines, including those with BRAF mutations.

Main Results:

• Three new hypothemycin analogues were successfully isolated and their structures determined.
• 4-O-demethylhypothemycin demonstrated significant and selective cytotoxic effects on cell lines with a BRAF mutation.
• The other two analogues showed moderate to no significant cytotoxic activity.

Conclusions:

• The fungal strains Hypomyces subiculosus DSM 11931 and DSM 11932 are a source of novel hypothemycin analogues.
• 4-O-demethylhypothemycin represents a promising lead compound for targeted cancer therapy, especially for BRAF-mutated cancers.
• Further investigation into the mechanism of action and in vivo efficacy of 4-O-demethylhypothemycin is warranted.